Assessment of an Intensive Motor Telerehabilitation Program for Stroke Patients

NCT07254195 | Recruiting

• 2 other identifiers: 69HCL24_05042025-A01054-45
• Study Type: interventional
• Target: 51
• Locations: 1 country
• Sites: 1

Brief Summary

Stroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitation to maximize recovery. However, after hospitalization, access to intensive rehabilitation is limited, due to geographical and mobility constraints, and the lack of reimbursement for private occupational therapy. Telerehabilitation, using digital technologies, can overcome these difficulties by offering interactive, accessible rehabilitation at home. Studies show that its effectiveness is comparable to that of clinical rehabilitation. Our study therefore proposes to evaluate the feasibility and effects of a home-based telerehabilitation program using the MindMotion GO device (MindMaze). This 12-week program aims to provide an additional intensive dose of rehabilitation to the standard of care, with 300 minutes of weekly active therapy, planned and monitored remotely by a therapist.

Conditions

Stroke

Keywords

Stroke; motor; telerehabilitation; intensive therapy

Outcome Measures

Primary Outcomes (1)

• Variation in the Goal Attainment Scale (GAS) score.

  The GAS is used to measure achievement of individual goals. GAS goals will be set for each participant before the start of the intervention. Achievement of each objective will be rated on a 5-point scale: -2 (patient's initial, pre-intervention level), -1 (progress towards goal, without complete attainment), 0 (expected level), +1 (goal achieved better than expected), +2 (best hoped-for result).

  Baseline, at 8, 20, 32 and 44 weeks

Study Arms (2)

TR1

OTHER

Immediately following discharge from the rehabilitation unit, patients will participate in a 12-weeks telerehabilitation program using the MindMotion GO device, in parallel to the standard care. During the 12-weeks program, patients will aim to achieve at least 300 minutes of active therapy time per week using the MindMotion GO device at their home. They will have 1 synchronous rehabilitation session per week in clinic or remotely via videoconference with a PT or an OT. The rest of the sessions will be done asynchronously and independently by the patient. The activity schedule will be drawn up by a therapist remotely and will be personalized for each patient. After 12 weeks, the patients will be asked whether they wish to continue with the telerehabilitation program. Patients who agree to continue will pursue the program for another 12 weeks, in parallel to standard care. Patients who do not want to continue the program will only receive standard care for the following 12 weeks.

Device: Telerehabilitation program using the MindMotion GO device

TR2

OTHER

Following discharge from the rehabilitation unit, patients will receive only standard care for 12 weeks. Then, they will start the telerehabilitation program using the MindMotion GO device for 12 weeks, in parallel to the standard care. During the 12-weeks program, patients will aim to achieve at least 300 minutes of active therapy time per week using the MindMotion GO device at their home. They will have 1 synchronous rehabilitation session per week in clinic or remotely via videoconference with a PT or an OT. The rest of the sessions will be done asynchronously and independently by the patient. The activity schedule will be drawn up by a therapist remotely and will be personalized for each patient.

Device: Telerehabilitation program using the MindMotion GO device

Interventions

Telerehabilitation program using the MindMotion GO device DEVICE

In parallel to the standard of care, patients will participate in a 12-weeks telerehabilitation program using the MindMotion GO device. MindMotion GO is a digital therapy device that offers a catalog of interactive games designed specifically for patients with neurological injuries. During the telerehabilitation program, patients will aim to achieve at least 300 minutes of active therapy per week. They will have 1 synchronous session per week in the clinic or remotely by videoconference with a therapist (PT or OT). Patients are expected to carry out the other planned sessions independently at home. The activity schedule will be drawn up by a remote therapist each week and will be personalized for each patient.

TR1; TR2

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Hospitalized for a first ischemic or hemorrhagic stroke
• Stroke occurrence more than 30 days prior
• Presenting motor deficits affecting the upper limb, with or without involvement of the lower limb
• Able to follow the instructions of the home program using the MindMotion GO device
• Having at home an accessible email address, an Internet connection with password, a smartphone, a screen or TV with HDMI input (Full HD 1080p resolution), and a free space of approximately 1 m x 2.5 m in front of the screen
• Ability to sit without assistance
• Patient agreeing to participate in the study by signing an informed consent form
• Affiliated with, or entitled to, a social security scheme

You may not qualify if:

• History of stroke
• Neurological pathology other than stroke
• Patient with uncontrolled epilepsy or seizure disorder
• Cardiac disease limiting exercise
• Pain limiting rehabilitation dose
• Major comprehension problems or severe psychiatric and/or cognitive disorders that could compromise understanding of the protocol and the smooth running of the study.
• Uncorrected hearing or visual deficits
• Severe apraxia
• Severe memory impairment
• Severe unilateral spatial neglect
• Total plegia of affected limb
• Pregnant, parturient or breast-feeding women
• Persons deprived of their liberty by judicial or administrative decision
• Persons admitted to a health or social institution for purposes other than research
• Adults under legal protection (guardianship, curatorship)

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Hopital Henry Gabrielle

Saint-Genis-Laval, Lyon, 69230, France

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Central Study Contacts

Jacques LUAUTÉ, MD

CONTACT

4 78 86 50 64; Jacques.luaute@chu-lyon.fr

Anne-Laure CHARLOIS

CONTACT

478 86 51 13; anne-laure.charlois@chu-lyon.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 19, 2025
• First Posted: November 28, 2025
• Study Start: February 25, 2026
• Primary Completion (Estimated): January 25, 2028
• Study Completion (Estimated): January 25, 2028
• Last Updated: March 5, 2026

Record last verified: 2026-03

Locations

FR (1)